Abstract
According to the “distorted key” theory as elaborated in a review article years ago (Chou, K.C.: Analytical Biochemistry, 1996, 233, 1-14), the knowledge of the cleavable peptides by SARS-CoV Mpro (severe acute respiratory syndrome coronavirus main proteinase) can provide very useful insights on developing drugs against SARS. In view of this, the softwares, ZCURVE_CoV 1.0 and ZCURVE_CoV 2.0 (http: / / tubic.tju.edu.cn / sars / ), developed recently for SARS-Coronavirus are used to analyze the 36 complete SARS-Coronavirus RNA sequences in the gene bank NCBI (http: / / www.ncbi.nlm.nih.gov / ) from different sources for protein coding genes, and to search for the cleavage sites of SARS-CoV Mpro in polyproteins pp1a and pp1ab. A total of 396 cleavage points are found in the 36 SARS-Coronavirus and 11 cleavable octapeptides abstracted from the 396 cleavage sites. The statistical distributions of amino acids for the cleavable octapeptides at the subsites R4, R3, R2, R1, R1, R2, R3 and R4 are calculated. The cleavage-specific positions are on R2, R1 and R1, and the positions R3 and R4 are featured by some certain specificity for SARS-CoV Mpro. The structural characters of amino acid residues around the cleavage-specific positions are discussed. Two most promising octapeptides, i.e., NH2-ATLQ↓AIAS-COOH and NH2-ATLQ↓AENV-COOH, are selected to be the candidates for chemical modification, converting into the inhibitors of SARS-CoV Mpro. A possible strategy to convert a cleavable octapeptide by SARS enzyme into a drug candidate against SARS is elucidated.
Keywords: sars, coronavirus, gene identification, sars-cov mpro, octapeptide, peptide bond modification, Inhibitor, distorted key theory
Medicinal Chemistry
Title: Application of Bioinformatics in Search for Cleavable Peptides of SARSCoV Mpro and Chemical Modification of Octapeptides
Volume: 1 Issue: 3
Author(s): Qishi Du, Shuqing Wang, Zhiqin Jiang, Weina Gao, Yun Li, Dongqing Wei and Kuo-Chen Chou
Affiliation:
Keywords: sars, coronavirus, gene identification, sars-cov mpro, octapeptide, peptide bond modification, Inhibitor, distorted key theory
Abstract: According to the “distorted key” theory as elaborated in a review article years ago (Chou, K.C.: Analytical Biochemistry, 1996, 233, 1-14), the knowledge of the cleavable peptides by SARS-CoV Mpro (severe acute respiratory syndrome coronavirus main proteinase) can provide very useful insights on developing drugs against SARS. In view of this, the softwares, ZCURVE_CoV 1.0 and ZCURVE_CoV 2.0 (http: / / tubic.tju.edu.cn / sars / ), developed recently for SARS-Coronavirus are used to analyze the 36 complete SARS-Coronavirus RNA sequences in the gene bank NCBI (http: / / www.ncbi.nlm.nih.gov / ) from different sources for protein coding genes, and to search for the cleavage sites of SARS-CoV Mpro in polyproteins pp1a and pp1ab. A total of 396 cleavage points are found in the 36 SARS-Coronavirus and 11 cleavable octapeptides abstracted from the 396 cleavage sites. The statistical distributions of amino acids for the cleavable octapeptides at the subsites R4, R3, R2, R1, R1, R2, R3 and R4 are calculated. The cleavage-specific positions are on R2, R1 and R1, and the positions R3 and R4 are featured by some certain specificity for SARS-CoV Mpro. The structural characters of amino acid residues around the cleavage-specific positions are discussed. Two most promising octapeptides, i.e., NH2-ATLQ↓AIAS-COOH and NH2-ATLQ↓AENV-COOH, are selected to be the candidates for chemical modification, converting into the inhibitors of SARS-CoV Mpro. A possible strategy to convert a cleavable octapeptide by SARS enzyme into a drug candidate against SARS is elucidated.
Export Options
About this article
Cite this article as:
Du Qishi, Wang Shuqing, Jiang Zhiqin, Gao Weina, Li Yun, Wei Dongqing and Chou Kuo-Chen, Application of Bioinformatics in Search for Cleavable Peptides of SARSCoV Mpro and Chemical Modification of Octapeptides, Medicinal Chemistry 2005; 1 (3) . https://dx.doi.org/10.2174/1573406053765468
DOI https://dx.doi.org/10.2174/1573406053765468 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Medicinal Chemistry of Nitrite as a Source of Nitric Oxide Signaling
Current Topics in Medicinal Chemistry Early Diagnosis of Alzheimers Disease: Is MCI Too Late?
Current Alzheimer Research Genetic and Epigenetic Biomarkers for Diagnosis, Prognosis and Treatment of Metabolic Syndrome
Current Pharmaceutical Design Limitations and Potential Clinical Application on Contrast Echocardiography
Current Cardiology Reviews Cancer Therapeutics-Related Cardiovascular Complications. Mechanisms, Diagnosis and Treatment
Current Pharmaceutical Design Coronary Pressure Measurement Based Decision Making for Percutaneous Coronary Intervention
Current Cardiology Reviews Progress Towards Clinically Useful Aldosterone Synthase Inhibitors
Current Topics in Medicinal Chemistry Aldosterone Receptor Antagonists and Cardiovascular Disease: Do We Need a Change of the Guard?
Cardiovascular & Hematological Agents in Medicinal Chemistry One-pot α-arylation of β-carboline with Indole and Naphthol Derivatives
Current Organic Synthesis Review of Clinic Trials: Agents Targeting c-Met
Reviews on Recent Clinical Trials Pharmacokinetic Modeling of Caco-2 Cell Permeability Using Genetic Programming (GP) Method
Letters in Drug Design & Discovery The Role of Pericytes in Neurovascular Unit: Emphasis on Stroke
Current Drug Targets Molecules to Selectively Target Receptors for Treatment of Pain and Neurogenic Inflammation
Recent Patents on Inflammation & Allergy Drug Discovery Intratubular Renin-Angiotensin System in Hypertension
Current Hypertension Reviews Statin Therapy and New-onset Diabetes: Molecular Mechanisms and Clinical Relevance
Current Pharmaceutical Design Involvement of Dietary Bioactive Proteins and Peptides in Autism Spectrum Disorders
Current Protein & Peptide Science Carfilzomib: A Tale of a Heartbreaking Moment: Case Report and Concise Review of the Literature
Cardiovascular & Hematological Disorders-Drug Targets Effect of Genetic Polymorphisms (SNPs) in CHRNA7 Gene on Response to Acetylcholinesterase Inhibitors (AChEI) in Patients with Alzheimer’s Disease
Current Drug Targets Subject Index To Volume 3
Current Neurovascular Research Potential Interactions of Carotenoids with Other Bioactive Food Components in the Prevention of Chronic Diseases
Current Bioactive Compounds